Issues

America is the world leader in medical innovation – to the benefit of patients and the U.S. economy.

America’s biopharmaceutical research companies support more than 3 million jobs around the country, paying roughly three times as much in federal and state taxes as employees in the rest of the economy. In addition, the sector’s direct contribution to GDP in 2008 (the most recent year that data were available) was approximately three and a half times the average contribution per sector in the rest of the economy.

Meanwhile, life expectancy in the U.S. is at a record level – former FDA commissioner Mark McClellan said that “new drugs are no small part of this medical miracle” – and once-fatal chronic diseases are now seen as controllable conditions.

Unfortunately, without sound policies that promote continued investment in innovation and a commitment to R&D (and the jobs that it provides), this global leadership is ours to lose.

News Updates

Get our free e-News updates for the latest, breaking news. Subscribe today.

America’s biopharmaceutical research sector is the global leader in medical innovation, with more than 300 new medicines approved... Read More	When disaster strikes, people need medical care, and they need medicine. That reality was never more apparent than after... Read More	For nearly 20 years, the mission of the Prescription Drug User Fee Act has been to advance public health, safeguard patient... Read More
Exposing the United States’ closed, carefully regulated pharmaceutical distribution system to imported medicines raises the risk... Read More	Nothing is more important to America's biopharmaceutical research companies than the safety and integrity of the medical... Read More	America’s pharmaceutical companies have long been advocates for consumer education on prescription drug abuse and the safe... Read More
The Food and Drug Administration has been a cornerstone in the fight to improve Americans’ health. Due to the vital nature of the... Read More	Research and development is expensive and risky. Only five out of 5,000 experimental compounds reach clinical trials, and only... Read More	America’s biopharmaceutical research companies lead the world in the discovery and development of new medicines. The medicines... Read More

Issues Sections

Drug Safety Nothing is more important to America's biopharmaceutical research companies than the safety and integrity of the medical products they develop. Ensuring that safety begins long before a therapy enters the marketplace and continues long after it is available to patients.	Food And Drug Administration The Food and Drug Administration has been a cornerstone in the fight to improve Americans’ health. Due to the vital nature of the FDA’s public health oversight, PhRMA stands behind an empowered agency that is adequately resourced through enhanced congressional appropriations to conduct its crucial...	Medical Advances America’s biopharmaceutical research companies lead the world in the discovery and development of new medicines. The medicines developed over the past several decades -- and the medical advances they represent -- have revolutionized the battle against disease and have saved and improved lives...
About The Biopharmaceutical Sector America’s biopharmaceutical research sector is the global leader in medical innovation, with more than 300 new medicines approved by the Food and Drug Administration in the last decade. In 2010, biopharmaceutical companies invested $67.4 billion on the discovery and development of medicines.	Importation Exposing the United States’ closed, carefully regulated pharmaceutical distribution system to imported medicines raises the risk of counterfeit or substandard drugs creeping into the medicine supply. The most common mechanism for counterfeit drugs to enter the U.S. drug supply is through purchases...	Adherence: Key Information on Managing and Treating Disease Successful management and treatment of disease requires consistent use of prescribed medicines. Unfortunately, according to recent research, as many as 75 percent of patients (and 50 percent of chronically ill patients) fail to adhere to – or comply with – physician prescribed treatment regimens.
Environmental Issues America’s pharmaceutical companies have long been advocates for consumer education on prescription drug abuse and the safe disposal of prescription medication. Its support of programs like the American Medicine Chest Challenge and SMARxT Disposal programs provide a free and simple solution for...	Intellectual Property Research and development is expensive and risky. Only five out of 5,000 experimental compounds reach clinical trials, and only one of those five eventually gain regulatory approval. Companies must be able to benefit from the incentives of intellectual property to protect their investments.	Prescription Drug User Fee Act For nearly 20 years, the mission of the Prescription Drug User Fee Act has been to advance public health, safeguard patient safety and give patients more timely access to new, life-saving medicines. The program was created in response to a perilous regulatory bottleneck that slowed patient access...
International Innovation, research and development aimed at finding tomorrow’s cures are a global concern, so PhRMA is engaged on an international scale. We work to ensure that the cures our member companies develop reach patients wherever they may be, and we inform policymakers and stakeholders of the policies...	Appropriate Use Of Medicines Everyone in the healthcare system shares the goal of helping each patient receive the best available treatment appropriate to his or her individual needs. As the knowledge of diseases and their treatment and prevention increases, prescription medicines justifiably are playing an increasingly...	Access and Affordability Biopharmaceutical companies recognize not everyone has access to the medicines they need. That is why they offer assistance to financially struggling, uninsured Americans through the Partnership for Prescription Assistance.
Medicare: Part D a Success Story for Seniors Since its inception, the Medicare prescription drug program has provided seniors unprecedented access to medicines at affordable prices.	Sales And Marketing Biopharmaceutical marketing plays a critical role in improving patient care and fostering the appropriate use of medicines. Giving physicians timely information about the medicines they prescribe clearly benefits patients and advances healthcare throughout the United States.

Your name
Your email
Recipient email(s) (separated by commas)
Subject

Issues

Subscribe to our Email Updates

Issues Sections